Abstract-The associations between injury severity, posttraumatic stress disorder (PTSD), and development of chronic diseases, such as hypertension, among military service members are not understood. We sought to (1) estimate the prevalence and incidence of PTSD within a severely injured military cohort, (2) assess the association between the presence and chronicity of PTSD and hypertension, and (3) 
W hile >52 000 service members have been injured in the wars in Iraq and Afghanistan, with the total cost for posttraumatic stress disorder (PTSD) from these wars projected to exceed $6 billion, 1 the prevalence and incidence of PTSD among severely wounded service members has not been reported. The development of PTSD has been linked to various negative outcomes, including reduced career opportunities, 2 substance abuse, 3 weight gain and obesity, [4] [5] [6] coronary artery disease, 7 hypertension, 6, 8, 9 and mortality, 7 including suicide. 10, 11 However, the interaction between physical and psychological trauma and their effects on chronic health outcomes is not as well understood.
In addition to physical damage, traumatic injury also leads to psychological distress. 12, 13 Physical 14, 15 and psychological [16] [17] [18] insults can both lead to chronic inflammatory responses, which have been implicated in the development of cardiovascular disease. [19] [20] [21] We previously reported that combat injury severity is associated with increased long-term risk of hypertension in injured service members, among other chronic conditions. 22 The risk of long-term morbidity could arise through multiple possible pathways. It is possible that the effect of the initial injury severity is mediated by the development of PTSD. In this case, increased injury severity is associated with higher risk of PTSD, which becomes the pathway through which hypertension arises. Our goals were to (1) estimate the prevalence and incidence of PTSD within a severely injured military cohort, (2) assess associations between the presence and chronicity of PTSD and hypertension, and (3) determine whether or not initial injury severity and PTSD are independent risk factors for development of hypertension.
Methods Population
Because of the sensitive nature of the military data collected for this study, requests to access the data set from qualified researchers trained in human subject confidentiality protocols may be made by submitting a data sharing application to the Defense Health Agency (https:// health.mil/Military-Health-Topics/Privacy-and-Civil-Liberties/ Submit-a-Data-Sharing-Application?type=Forms+%26+Templates). Demographic and injury-specific data for US military service members injured in combat during either the Iraq or Afghanistan conflicts between February 1, 2002, and February 1, 2011, were retrospectively collected from the Department of Defense Trauma Registry and were combined with data on deaths from the Armed Forces Medical Examiner System and longitudinal follow-up data from Defense Health Agency administrative databases. To be included, an individual had to be injured severely enough to require admission to an intensive care unit. The data collection, compilation, and flow are described in detail in previous publications. 22, 23 The study was conducted under a protocol that was approved by the US Army Medical Research and Materiel Command Institutional Review Board.
Measures
We used International Classification of Diseases, Ninth Revision (ICD-9), clinical modification codes for up to a 10-year followup period to determine each instance of a PTSD and hypertension diagnosis after combat injury (Table S1 in the online-only Data Supplement). ICD-9 diagnosis codes, entered at the discretion of the treating physician, were collected from Defense Health Agency administrative databases for outpatient clinical encounters within the Department of Defense hospital system and from TRICARE billed encounters in civilian facilities.
Patients who had ICD-9 diagnosis codes for hypertension before the date of injury were excluded from the analysis. In addition, because hypertension diagnoses made within the first 90 days of injury may simply be related to complications arising from the initial trauma rather than onset of a chronic medical condition, a second hypertension ICD-9 code was required after 90 days. 22 Patients were identified as having the diagnosis if the diagnosis was coded after 90 days or not having the diagnosis if it was not coded.
PTSD diagnosis codes were included if they occurred after the date of initial injury and before the date of hypertension diagnosis or censoring. For individuals who met this condition, the number of unique clinical encounters with at least 1 PTSD diagnosis code was summed for the entire follow-up period and split into chronicity categories to account for potential differences in symptom severity. We did this by categorizing the count of PTSD diagnosis encounters as either (1) no PTSD diagnoses, (2) 1 to 15 PTSD diagnoses, and (3) >15 PTSD diagnoses, based on cutoff values that were empirically determined to yield the best model fit.
To control for nonrandomization and potential confounding, we included patient demographic variables (age, sex, and race), baseline physiological measures (heart rate and mean arterial pressure [MAP]), and indicators of injury type and severity (burn injury, acute kidney injury, and injury severity score [ISS] ). Age was measured as the age in years at the time of injury. Sex was categorized as either men or women. Race was categorized as black, white, other, or missing based on the Department of Defense administrative databases. Heart rate was measured as a continuous variable based on the presenting heart rate at the time of admission to the initial medical treatment facility. We categorized continuous MAP values to reflect hypotension that might require intervention (MAP, <65 mm Hg 24 ) as low and acute hypertension (MAP, >106 mm Hg 25 ) as high. The presence of burn injury was categorized as a yes-no binary indicator. As in previous work, 22 the Kidney Disease Improving Global Outcomes creatinine criteria 26 was used to determine whether or not patients experienced acute kidney injury. The CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation 27 was used to estimate baseline serum creatinine levels, assuming an estimated glomerular filtration rate of 100 mL/min per 1.73 m 2 . The overall severity of the initial injury was measured using the ISS 28 -a validated scoring system for patients with trauma based on body regions and anatomic structures, with scores ranging from 1 to 75, and each increment representing a corresponding increase in injury severity. In multivariate analyses, ISS was rescaled to represent 5-point increments for ease in interpretation of hazard ratios (HRs).
Statistical Analysis
Descriptive statistics are presented as mean and SD for interval numeric variables and percentages for categorical variables, with the exception of ISS and follow-up time, which are presented as median and interquartile range (IQR) because of non-normality. Unadjusted aggregate incidence rates for hypertension were calculated as the number of individuals with hypertension diagnoses per 1000 personyears and were compared between PTSD diagnosis groups. Risk ratios (RRs) for each PTSD diagnosis group were calculated by dividing the observed RR by the incidence rate for the overall cohort. Outcomes of hypertension and death were considered competing events and were analyzed using the Fine and Gray competing risk regression methodology. 29 Cumulative incidence function curves generated from the fully adjusted multivariable model were compared using Gray weighted log-rank test. 30 Both unadjusted and multivariable competing risk regression models were used to test hypotheses that chronicity of PTSD diagnoses and ISS are independently associated with hypertension. We estimated competing risk models for PTSD and ISS as (1) unadjusted, (2) multivariable model adjusted for age, race, and initial physiological and injury characteristics, and (3) multivariable model adjusted for age, race, initial physiological and injury characteristics, and a count of the total number of clinical encounters per year. Overall model fit was assessed using the Akaike information criterion (AIC) and by assessing HRs and 95% confidence intervals (CIs). 31 Sensitivity analyses were conducted to assess the robustness and influence of extreme values. Additional sensitivity analyses were done using an alternate definition of hypertension. This definition was based on a prescription for an antihypertensive medication (Table S2 ). The proportional hazards assumption was assessed using Schoenfeld and Martingale residuals, and the results indicated the assumption was not violated. All analyses were conducted using SAS, version 9.4 (SAS Institute, Cary, NC). Significance testing is reported with actual P values.
Results
Of 6011 candidate patients, 3846 met criteria for inclusion in the study ( Figure S1 ). Descriptive statistics are reported overall and by PTSD diagnosis groups in Table 1 . The mean age at time of injury was 26 years (SD=6.1), and the racial composition was 5.3% black, 55.9% white, 8.4% other, and 30.5% without a racial indicator in their records. Mean heart rate on initial admission was 98.1 (SD=25), and MAP was 87.8 (SD=18.5). The percent of the cohort with abnormally high MAP was 13.9%, and the percent with abnormally low MAP was 10.5%. Median ISS was 17 (IQR=10-25), and the percentages with burn injury or acute kidney injury were 19.5% and 11.7%, respectively.
The overall prevalence of any PTSD diagnosis was 42.4%, overall prevalence of hypertension was 14.3%, and overall mortality was 1%. Median follow-up time was 4 years (IQR=2.1-6.5), and the median time from first PTSD diagnosis to first hypertension diagnosis was 2.3 years (IQR=0.9-4.8)
for patients with 1 to 15 PTSD diagnosis encounters and 2.9 years (IQR=1.5-5.3) for patients with >15 PTSD diagnosis encounters. The unadjusted incidence rate of PTSD was 106 per 1000 person-years. The unadjusted incidence rate of hypertension per 1000 person-years was 32.6, which differed significantly by PTSD diagnosis group (Figure 1) . Patients with no PTSD diagnoses had a hypertension incidence rate of 25.3 (RR, 0.78; 95% CI, 0.65-0.90); patients with 1 to 15 PTSD diagnosis encounters had a hypertension incidence rate of 46.4 (RR, 1.43; 95% CI, 1.20-1.65), 43% higher than the overall incidence rate; and patients with >15 PTSD diagnosis encounters had a hypertension incidence rate of 59.7 (RR, 1.83; 95% CI, 1.50-2.17), 83% higher than the overall incidence rate for this cohort.
Results of unadjusted and multivariable-adjusted competing risk regression models are reported in Additionally, sensitivity analyses showed that the findings presented were robust to the exclusion of cases with either extremely low (<10th percentile) or extremely high (>90th percentile) number of clinical encounters (Table S3) . We also modeled the PTSD variable as a binary indicator (AIC=8436) as a linear effect (AIC=8474) and categorization based on multiple cut points, all of which indicated a significant association with hypertension (Table S4) . We chose the 3-level threshold categorization presented here because this form yielded the lowest AIC value (AIC=8434), indicating superior model fit. Further sensitivity analyses defining hypertension as a prescription for an antihypertensive medication and the combination of either an ICD-9 code or antihypertensive prescription did not materially change the PTSD or ISS associations with subsequent hypertension (Table S5) Cumulative incidence plots from the fully adjusted model (model 3) demonstrate that initial injury severity and PTSD diagnosis act as independent risk factors for hypertension (Figure 2A) . Patients with ISS scores >25 (top quartile) and patients who have been diagnosed with PTSD exhibit proportional and additive increases in hypertension risk, such that individuals with both ISS scores >25 and a PTSD diagnosis have the greatest hypertension risk (Figure 2A , line A), followed by patients with a PTSD diagnosis but not a high ISS (Figure 2A 
Discussion
We report for the first time the overall prevalence (42.4%) and incidence rate (106 per 1000 person-years) of PTSD in a cohort of military service members who were severely injured during the wars in Iraq and Afghanistan. Consistent The overall incidence rate of hypertension in this cohort is 32.6 per 1000 person-years. Incidence rates increase in a dose-response manner as the number of posttraumatic stress disorder (PTSD) diagnosis encounters increases. Relative risk for each PTSD group was calculated by dividing the corresponding incidence rate by the overall incidence rate for the entire cohort and is represented as risk ratio (RR; 95% confidence interval).
with previous findings, 22, 32 we found that initial injury severity was independently associated with long-term development of hypertension, even when adjusting for potential mediation of this relationship by the development of PTSD. The most conservative estimate is that for every 5-point increase in ISS, hypertension risk increases by 5%. For example, an individual with an ISS of 40 has an estimated 30% higher risk of developing hypertension, compared with an individual with an ISS of 10, all else being equal. This estimate did not change when accounting for PTSD diagnoses and only changed from 6% to 5% per 5-point interval when the total number of clinical encounters was included in the model. Additionally, we found that PTSD diagnoses chronicity exhibits a similar but independent association with hypertension. In the fully adjusted model, patients who had between 1 and 15 PTSD diagnosis encounters had an 85% increase in the risk of hypertension, whereas patients with >15 PTSD diagnosis encounters had a 114% increase in hypertension risk, compared with patients without PTSD diagnoses.
Prevalence and Incidence of PTSD
Early estimates of PTSD prevalence among Operation Iraqi Freedom and Operation Enduring Freedom veterans reported in 2004 ranged from 6.2% to 19.9%, depending on PTSD definition criteria, the service branch, and deployment theater. 33 Estimates reported in 2009 were higher, at 24%. 6 Our estimate of 42.4% within a severely injured cohort is almost twice as high as these previous estimates for the general population of Operation Iraqi Freedom and Operation Enduring Freedom veterans, suggesting that combat injury may exacerbate PTSD risk. This is consistent with findings reported within the Millennium Cohort study, 34 which found a linear increase in the odds of self-reported PTSD diagnoses associated with the severity of combat injury within a small (n=183) subgroup of injured veterans. A unique strength of our study, however, is that it is based on a large cohort of injured service members with ≤10 years of subsequent follow-up and ICD-9 diagnosis codes for defining the outcomes of PTSD and hypertension. 
Links Between Initial Injury Severity, PTSD, and Hypertension
We previously reported an association between initial injury severity and hypertension risk among injured service members and proposed that PTSD may function as a mediator of this risk. 22 However, the present findings do not support the hypothesis that hypertension risk associated with initial injury severity works through subsequent development of PTSD. Rather, our data suggest that initial injury severity and PTSD operate as independent risk factors for hypertension. Our estimated effect sizes for PTSD, HRs of 1.85 for individuals with 1 to 15 diagnosis codes and 2.14 for individuals with >15 diagnosis codes, were similar to estimates from previous studies, 6 and the effects were robust even when adjusting for the total number of medical encounters and in sensitivity analyses. Although these results do not completely rule out mental health as a pathway, they suggest that more attention must be paid to the possibility that the ISS-hypertension association may operate through inflammatory, behavioral, or other pathways ( Figure 3) .
There is growing evidence in support of the inflammation hypothesis as an explanation for the link between initial injury severity and hypertension. Earlier work on physiological and psychological stress 16 demonstrated links between increases in neuroendocrine hormones, 17, 35, 36 proinflammatory cytokines, 20 and other markers of inflammation 19 and subsequent development of many diseases of aging, including hypertension and other cardiovascular diseases. 21 More recent studies focusing on the impact of severe traumatic injury have shown similar systemic physiological and genomic responses after injury.
14 In addition to inflammation, health behaviors, such as smoking, alcohol, substance abuse, poor diet, obesity, and reduced physical activity, have all been implicated as cardiovascular disease [37] [38] [39] [40] risk factors. Changes in these behaviors after injury may play an important role in mediating hypertension risk. Although the present study cannot address either of these considerations directly, our findings do support the need for further investigation of both inflammatory and behavioral pathways as possible links between injury severity and longer term development of hypertension and other chronic diseases.
Implications for Veterans Health Care
The implications for medical care resources associated with combat injury-related morbidities could be significant. There are ≈23 000 Operation Iraqi Freedom and Operation Enduring Freedom service members 41 who were injured severely enough to be hospitalized, and the existing prevalence of PTSD and hypertension in this cohort suggests that as many as 9800 could already have PTSD and 3200 could already have hypertension. Based on the average yearly direct costs of treating PTSD 1, 42 and hypertension, 43 $4100 and $700, respectively, a rough annual cost of ≈$42.4 million could be attributable to these conditions within the injured population. During the course of potential decades of treatment, the costs could exceed $1 billion. This is a conservative estimate because it does not account for any direct costs of other comorbidities or indirect costs. Furthermore, these direct costs may increase as the incidence and prevalence of PTSD and hypertension continue to grow as this injured cohort ages. Increases in PTSD, hypertension, and other chronic medical conditions, within Operation Iraqi Freedom and Operation Enduring Freedom veterans, could create additional strain for an already strained Veteran's Affairs Healthcare System. Previous work has demonstrated increased risk of coronary artery disease, diabetes mellitus, and chronic kidney disease within this same population.
22

Limitations
Although these data shed light on the subsequent health risks facing injured veterans, there are limitations that must be acknowledged. First, the retrospective observational design limited our ability to control potential bias from differences in methods of blood pressure measurement during the follow-up period. However, our study is strengthened by our ability to follow a specific cohort longitudinally and measure the development of PTSD and hypertension using administrative and clinical databases, as opposed to self-report or cross-sectional data only. Moreover, ICD-9 may be likely to be more specific than sensitive, 44 and as a result, our findings may underestimate the excess risk of PTSD and hypertension, although sensitivity analyses suggest that results would be similar if hypertension was defined more broadly as ICD-9 or antihypertension medication usage. Second, we do not currently have measures of other potential explanatory pathways, such as inflammatory markers or behavioral indicators like body mass index, which would allow us to better control potential confounding and further test mediation hypotheses. However, we were able to control for potential indication bias by including a measure of the total number of clinical encounters as a covariate in our models, which helps mitigate at least 1 likely source of confounding. The fact that the median number of clinical encounters is high (179 overall and 149 for the non-PTSD group) and that our results were robust to inclusion of the total number of encounters in multivariable models and in sensitivity analyses further strengthens our results and defuses counterarguments that hypertension is simply being measured in patients who are being seen more often. Third, although we have followed this cohort for ≤10 years, the median followup time is only 4 years. It is likely that more follow-up time is required to observe additional incidence of hypertension and other less prevalent chronic health conditions. Moreover, we were unable to assess the specific course of treatments for initial injuries and subsequent PTSD symptoms in these data, which may also impact longer term chronic health risks. Future studies would benefit from more detailed analysis of associations between treatment course and outcomes.
Perspectives
In a cohort of young service members injured in combat, we found that the chronicity of PTSD diagnoses after injury and the severity of the initial injury were independent risk factors for subsequent development of hypertension. These findings reinforce previous results linking injury severity to increased hypertension risk 22, 32 and suggest that the compounded burden of mental and physical limitations for severely injured individuals may lead to additional chronic disease, potentially premature mortality, and greater costs for care related to these service-connected illnesses.
